Skip to Main Content

Author Details

Jennifer A Doherty
Huntsman Cancer Institute, University of Utah
2004
206
50
PMIDPaper TitleJournal TitlePublished Year
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
35534206Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study.J Med Genet2023
37671166A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome.Front Immunol2023
36826816Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility.JAMA Netw Open2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
37220873Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case-Control Study from the Ovarian Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2023
37671166A single center case series of immune checkpoint inhibitor-induced type 1 diabetes mellitus, patterns of disease onset and long-term clinical outcome.Front Immunol2023
35534206Familial risk of epithelial ovarian cancer after accounting for gynaecological surgery: a population-based study.J Med Genet2023
37220873Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case-Control Study from the Ovarian Cancer Association Consortium.Cancer Epidemiol Biomarkers Prev2023
36688720Lifetime ovulatory years and risk of epithelial ovarian cancer: a multinational pooled analysis.J Natl Cancer Inst2023
36826816Association of Frequent Aspirin Use With Ovarian Cancer Risk According to Genetic Susceptibility.JAMA Netw Open2023
34776242Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.Gynecol Oncol2022
36182623Effects of risk factors for ovarian cancer in women with and without endometriosis.Fertil Steril2022
35511751Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study.Cancer Epidemiol Biomarkers Prev2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
36333689Pathways to ovarian cancer diagnosis: a qualitative study.BMC Womens Health2022
35064059Reproductive Factors Do Not Influence Survival with Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2022
34982317Ethnicity, socioeconomic status, income inequality, and colorectal cancer outcomes: evidence from the 4C2 collaboration.Cancer Causes Control2022
34789471High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2022
35244678Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma.Cancer Epidemiol Biomarkers Prev2022
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
34776242Endometriosis and menopausal hormone therapy impact the hysterectomy-ovarian cancer association.Gynecol Oncol2022
34823030Class imbalance in out-of-distribution datasets: Improving the robustness of the TextCNN for the classification of rare cancer types.J Biomed Inform2022
35101137Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.Eur J Med Res2022
35511751Body Mass Index and Mammographic Density in a Multiracial and Multiethnic Population-Based Study.Cancer Epidemiol Biomarkers Prev2022
36182623Effects of risk factors for ovarian cancer in women with and without endometriosis.Fertil Steril2022
36210504Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci.J Natl Cancer Inst2022
36333689Pathways to ovarian cancer diagnosis: a qualitative study.BMC Womens Health2022
35101137Gene-gene interaction of AhRwith and within the Wntcascade affects susceptibility to lung cancer.Eur J Med Res2022
34982317Ethnicity, socioeconomic status, income inequality, and colorectal cancer outcomes: evidence from the 4C2 collaboration.Cancer Causes Control2022
35244678Racial Differences in the Tumor Immune Landscape and Survival of Women with High-Grade Serous Ovarian Carcinoma.Cancer Epidemiol Biomarkers Prev2022
35064059Reproductive Factors Do Not Influence Survival with Ovarian Cancer.Cancer Epidemiol Biomarkers Prev2022
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
34823030Class imbalance in out-of-distribution datasets: Improving the robustness of the TextCNN for the classification of rare cancer types.J Biomed Inform2022
34789471High Prediagnosis Inflammation-Related Risk Score Associated with Decreased Ovarian Cancer Survival.Cancer Epidemiol Biomarkers Prev2022
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
34236573Pre-diagnosis neutrophil-to-lymphocyte ratio and mortality in individuals who develop lung cancer.Cancer Causes Control2021
33750288Deep active learning for classifying cancer pathology reports.BMC Bioinformatics2021
33635801Limitations of Transformers on Clinical Text Classification.IEEE J Biomed Health Inform2021
33619020Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.Cancer Epidemiol Biomarkers Prev2021
33501497Pathology Laboratory Policies and Procedures for Releasing Diagnostic Tissue for Cancer Research.Arch Pathol Lab Med2021
32546565Population-based targeted sequencing of 54 candidate genes identifies <i>PALB2</i> as a susceptibility gene for high-grade serous ovarian cancer.J Med Genet2021
32766851Expanding Our Understanding of Ovarian Cancer Risk: The Role of Incomplete Pregnancies.J Natl Cancer Inst2021
32924180Integration of multiomic annotation data to prioritize and characterize inflammation and immune-related risk variants in squamous cell lung cancer.Genet Epidemiol2021
33105052Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium.Int J Cancer2021
34553212Genetic demultiplexing of pooled single-cell RNA-sequencing samples in cancer facilitates effective experimental design.Gigascience2021
34428202miQC: An adaptive probabilistic framework for quality control of single-cell RNA-sequencing data.PLoS Comput Biol2021
33619020Depot-Medroxyprogesterone Acetate Use Is Associated with Decreased Risk of Ovarian Cancer: The Mounting Evidence of a Protective Role of Progestins.Cancer Epidemiol Biomarkers Prev2021
33635801Limitations of Transformers on Clinical Text Classification.IEEE J Biomed Health Inform2021
  • 1 - 50 of 412

Recommended Authors

Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 5
SLR Consulting (Canada) Ltd
Career Start Year 2012
Number of shared co-authors 5
Indiana University School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Mayo Clinic
Career Start Year 2007
Number of shared co-authors 51
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 33
British Columbia Women's Hospital and Health Centre
Career Start Year 2004
Number of shared co-authors 40
Boston Children's Hospital and Harvard Medical School
Career Start Year 2004
Number of shared co-authors 50
Clinical Investigations Branch, National Cancer Institute
Career Start Year 2004
Number of shared co-authors 20
National Cancer Institute
Career Start Year 2004
Number of shared co-authors 30
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 9
Maastricht University Medical Center+
Career Start Year 2003
Number of shared co-authors 5
National Cancer Institute
Career Start Year 2003
Number of shared co-authors 123
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
The First Hospital of Lanzhou University
Career Start Year 2002
Number of shared co-authors 10
Mailman School of Public Health, Columbia University
Career Start Year 2001
Number of shared co-authors 25
Institute for Human Genetics, University of California San Francisco (UCSF)
Career Start Year 2001
Number of shared co-authors 87
University of British Columbia
Career Start Year 2000
Number of shared co-authors 35
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 33
National Cancer Institute, National Institutes of Health
Career Start Year 1999
Number of shared co-authors 28
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 5
Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center
Career Start Year 1998
Number of shared co-authors 75
Dana Farber Cancer Institute.
Career Start Year 1997
Number of shared co-authors 20
Institut de Recherche en Cancerologie de Montpellier
Career Start Year 1993
Number of shared co-authors 25
Women's Health Integrated Research Center, Inova Health System
Career Start Year 1992
Number of shared co-authors 67
Fred Hutchinson Cancer Research Center
Career Start Year 1991
Number of shared co-authors 10
Princess Margaret Cancer Centre
Career Start Year 1991
Number of shared co-authors 18
National Cancer Institute.
Career Start Year 1990
Number of shared co-authors 57
Princess Margaret Cancer Centre, University Avenue
Career Start Year 1990
Number of shared co-authors 54
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 56
National Cancer Institute, 9609 Medical Center Dr
Career Start Year 1981
Number of shared co-authors 110

Collaborators

Fred Hutchinson Cancer Research Center
Co-authored papers 112
Rollins School of Public Health, Emory University
Co-authored papers 107
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 104
University of Michigan School of Public Health ann arbor
Co-authored papers 104
Duke School of Medicine
Co-authored papers 101
University of Southern California
Co-authored papers 100
Mayo Clinic College of Medicine
Co-authored papers 84
Memorial Sloan-Kettering Cancer Center
Co-authored papers 81
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 81
German Cancer Research Center (DKFZ)
Co-authored papers 80
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 80
College of Nursing, University of South Florida
Co-authored papers 80
Cedars-Sinai Medical Center
Co-authored papers 80
University of California irvine
Co-authored papers 78
National Cancer Institute, National Institutes of Health
Co-authored papers 75
UCL EGA Institute for Women's Health, University College London
Co-authored papers 74
Co-authored papers 72
Co-authored papers 65
University of Cambridge
Co-authored papers 63
The M. Sklodowska-Curie Cancer Center and Institute of Oncology
Co-authored papers 62
Co-authored papers 61
QIMR Berghofer Medical Research Institute
Co-authored papers 61
H. Lee Moffitt Cancer Center and Research Institute
Co-authored papers 59
Co-authored papers 56
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center
Co-authored papers 56
National Cancer Institute
Co-authored papers 56
Otto-Friedrich-University Bamberg
Co-authored papers 51
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 49
University of Hawaii Cancer Center
Co-authored papers 49
Co-authored papers 48